(Q43103702)

13 November 2017

The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats (English)

1 reference

13 November 2017

1 reference

1 reference

1

Subramanyam N Murthy

1 reference

13 November 2017

7

Philip J Kadowitz

1 reference

13 November 2017

4

Adeleke M Badejo

1 reference

13 November 2017

Rose-Claire St Hilaire

2

1 reference

13 November 2017

David B Casey

3

1 reference

13 November 2017

Jennifer McGee

5

1 reference

13 November 2017

Dennis B McNamara

6

1 reference

13 November 2017

Vivian A Fonseca

8

1 reference

13 November 2017

language of work or name

English

0 references

publication date

2 March 2010

1 reference

Diabetes and Vascular Disease Research

13 November 2017

1 reference

13 November 2017

7

1 reference

13 November 2017

2

1 reference

13 November 2017

138-144

1 reference

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

13 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Cardiometabolic risk: a Framingham perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Evaluation of insulin resistance in normoglycemic patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Glycemic targets for patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

The role of gut hormones in glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Incretin-based therapies in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Incretin-based therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Exenatide improves hypertension in a rat model of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

The role of carotid arterial intima-media thickness in predicting clinical coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Measurement of protein using bicinchoninic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109360269

21 January 2018

Identifiers

DOI

10.1177/1479164109360269

1 reference

13 November 2017

1 reference